A transcriptionally-definable subgroup of triple-negative breast and ovarian cancer samples shows sensitivity to HSP90 inhibition

av Shee, Kevin, Wells, Jason D., Ung, Matthew, Hampsch, Riley A., Traphagen, Nicole A., Yang, Wei, Liu, Stephanie, Zeldenrust, Megan A., Wang, Liewei, Kalari, Krishna R., Yu, Jia, Boughey, Judy C., Demidenko, Eugene, Kettenbach, Arminja N., Cheng, Chao, Goetz, Matthew P., Miller, Todd W.
I publikationen Clin Cancer Res (2019)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

av Jayaraman, Swaathi, Hou, Xiaonan, Kuffel, Mary J., Suman, Vera J., Hoskin, Tanya L., Reinicke, Kathryn E., Monroe, David G., Kalari, Krishna R., Tang, Xiaojia, Zeldenrust, Megan A., Cheng, Jingfei, Bruinsma, Elizabeth S., Buhrow, Sarah A., McGovern, Renee M., Safgren, Stephanie L., Walden, Chad A., Carter, Jodi M., Reid, Joel M., Ingle, James N., Ames, Matthew M., Hawse, John R., Goetz, Matthew P.
I publikationen Breast Cancer Res (2020)